NASDAQ:IPSC

Century Therapeutics Stock Insider Trading

etoro logo Buy IPSC
*Your capital is at risk
$2.07
-0.100 (-4.61%)
At Close: Jun 03, 2026

Century Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 75.05. In total, the insiders bought 11.54M and sold 270.87K IPSC shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
75.05
Buy 11.54M shares
Sell 270.87K shares
54% Buy Activity
Negligible or No Correlation
Sell Signal Low Confidence
Mar 12, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 75.05.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Dec 09, 2025
Buy
Stock Option (right to buy)
A-Award
Lee Han Myung
Director
Director 88 000
Value: $52.1K
Dec 09, 2025
Buy
Common Stock
J-Other
Lee Han Myung
Insider
Other 0
Value: $0
Dec 08, 2025
Sell
Common Stock
S-Sale
Carr Douglas
SVP Finance & Operations
Officer 257
Value: $137
Dec 08, 2025
Sell
Common Stock
S-Sale
Russotti Gregory
See Remarks
Officer 526
Value: $280
Nov 20, 2025
Sell
Common Stock
S-Sale
Cowan Chad
Chief Scientific Officer
Officer 5 462
Value: $3K
Nov 19, 2025
Buy
Common Stock
P-Purchase
Pfeiffenberger Brent
President And CEO
CEO / President 35 000
Value: $17.3K
Nov 17, 2025
Sell
Common Stock
S-Sale
Pfeiffenberger Brent
President And CEO
CEO / President 32 456
Value: $14.7K
Nov 03, 2025
Sell
Common Stock
S-Sale
Carr Douglas
SVP Finance & Operations
Officer 292
Value: $171
Sep 18, 2025
Buy
Common Stock
A-Award
Cowan Chad
Chief Scientific Officer
Officer 762 543
Value: $386.6K
Sep 18, 2025
Buy
Common Stock
A-Award
Cowan Chad
Chief Scientific Officer
Officer 762 543
Value: $386.6K
Sep 08, 2025
Sell
Common Stock
S-Sale
Carr Douglas
SVP Finance & Operations
Officer 263
Value: $132
Sep 08, 2025
Sell
Common Stock
S-Sale
Pfeiffenberger Brent
President And CEO
CEO / President 488
Value: $244
Sep 08, 2025
Sell
Common Stock
S-Sale
Russotti Gregory
See Remarks
Officer 539
Value: $270
Sep 08, 2025
Sell
Common Stock
S-Sale
Russotti Gregory
See Remarks
Officer 539
Value: $270
Sep 08, 2025
Sell
Common Stock
S-Sale
Pfeiffenberger Brent
President And CEO
CEO / President 488
Value: $244
Sep 08, 2025
Sell
Common Stock
S-Sale
Carr Douglas
SVP Finance & Operations
Officer 263
Value: $132
Aug 14, 2025
Buy
Common Stock
A-Award
Pfeiffenberger Brent
President And CEO
CEO / President 1 587 614
Value: $873.2K
Aug 14, 2025
Buy
Common Stock
A-Award
Pfeiffenberger Brent
President And CEO
CEO / President 1 587 614
Value: $873.2K
Aug 04, 2025
Sell
Common Stock
S-Sale
Carr Douglas
SVP Finance & Operations
Officer 296
Value: $158
Aug 04, 2025
Sell
Common Stock
S-Sale
Carr Douglas
SVP Finance & Operations
Officer 296
Value: $158
Jun 12, 2025
Buy
Stock Option (right to buy)
A-Award
Blackwell Kimberly
Director
Director 44 000
Value: $26.4K
Jun 12, 2025
Buy
Stock Option (right to buy)
A-Award
Jimenez Joseph
Director
Director 44 000
Value: $26.4K
Jun 12, 2025
Buy
Stock Option (right to buy)
A-Award
Riva Alessandro
Director
Director 44 000
Value: $26.4K
Jun 12, 2025
Buy
Stock Option (right to buy)
A-Award
Carlo Rizzuto
Director
Director 44 000
Value: $26.4K
Jun 12, 2025
Buy
Stock Option (right to buy)
A-Award
Quimi Daphne
Director
Director 44 000
Value: $26.4K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT CENTURY THERAPEUTICS, INC.
Century Therapeutics
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 for relapsed, refractory B-cell lymphoma. It is also developing CNTY-103, a CAR-iNK candidate targeting C...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE